Investor Relations

News

March 25, 2021

Jenoptik expects significant and profitable growth in 2021

March 24, 2021

Jenoptik successfully places 400 million euro debenture bond

February 22, 2021

Jenoptik and 4JET jointly launch new technology

Last Tick:	4/9/2021 5:35 PM
Last Price:	26,04€
Perf.%:	-0,61
Volume:	92.891
ISIN:	DE000A2NB601
Exchange:	Xetra

Investor Information

Facts and Figures

Jenoptik at a glance for investors — **Jenoptik at a glance**

read more

Share Information for Investors — **Share**

read more

News and Adhoc releases for Investors — **Adhoc releases and IR news**

read more

Corporate Governance at Jenoptik — **Corporate Governance**

read more

**Reports and Presentations**

read more

Annual General Meeting

Online Annual Report
Factsheet

Next financial dates:

08.08.2019, 6-month Report 2019
12.11.2019, 9-month Report 2019

Financial calendar

Investor Relations

+49 3641 65-2156

+49 3641 65-2804

Personal Information

Name *

Company

Country

Phone

E-mail *

Please do not fill in this field.

Your inquiry

Message

I am a Jenoptik customer already.

CustomerNumber

I consent that JENOPTIK AG or the Jenoptik Group company responsible for my request may process my e-mail address and my other personal data entered in the contact form in order to contact me by e-mail, telephone or otherwise and send me information on products and services offered by the Jenoptik Group. I am entitled at any time to receive information on the personal data stored about me and I can request the rectification, erasure or blocking of individual personal data. I can withdraw this declaration of consent at any time without giving reasons. Besides, I took notice of the Data protection declaration on the contact form. *

* = mandatory field, please complete

Investor Relations

News

Jenoptik expects significant and profitable growth in 2021

Jenoptik successfully places 400 million euro debenture bond

Jenoptik and 4JET jointly launch new technology

Aktien

Facts and Figures

Quick Info

Do you have any questions? Please contact us for advice.

Investor Relations

Personal Information

Your inquiry